NPPB and hydrops fetalis: This study will evaluate the effects of sacubitril/valsartan versus valsartan monotherapy on NT-proBNP levels, clinical outcomes, safety, and tolerability in HFpEF patients after being hospitalized for acute decompensated HF [16].